Assignee
SURFACE ONCOLOGY INC
US·6 granted patents·9 pending applications·12 citations·filing 2018–2023
Top patents by PatentIndex Score
15 records- 0188US10793637B2Antibodies that bind CD39 and uses thereofSURFACE ONCOLOGY INC·Filed 2020·Granted Oct 6, 2020·2 cites·20 claims
- 0286US11214619B2Anti-CD112R compositions and methodsSURFACE ONCOLOGY INC·Filed 2019·Granted Jan 4, 2022·4 cites·19 claims
- 0385US10738128B2Antibodies that bind CD39 and uses thereofSURFACE ONCOLOGY INC·Filed 2019·Granted Aug 11, 2020·2 cites·19 claims
- 0483US11332524B2Anti-IL-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2019·Granted May 17, 2022·2 cites·19 claims
- 0579US11655303B2Anti-CD39 antibody compositions and methodsSURFACE ONCOLOGY INC·Filed 2020·Granted May 23, 2023·1 cites·19 claims
- 0676US11279758B2Anti-CD112R compositions and methodsSURFACE ONCOLOGY INC·Filed 2019·Granted Mar 22, 2022·1 cites·22 claims
- 0767US2023042258A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 0866US2020399394A1Antibodies That Bind CD39 and Uses ThereofSURFACE ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0957US2024026001A1Use of anti-il-27 antibodiesSURFACE ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1057US2024025987A1Use of anti-il-27 antibodiesSURFACE ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1155US2021115127A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1255US2022389115A1Methods of Treating Cancer with an Anti-CD39 AntibodySURFACE ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1354US2023036592A1Methods of treating cancer with an anti-cd39 antibody and pembrolizumabSURFACE ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1447US2024279342A1Compositions and methods for immunotherapySURFACE ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1546US2019062428A1Combination of anti-cd47 antibodies and cell death-inducing agents, and uses thereofSURFACE ONCOLOGY INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →